PharVision Advisers’s Heartland Express HTLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,960
Closed -$370K 354
2025
Q4
$370K Buy
+40,960
New +$341K 0.19% 153
2025
Q2
Sell
-36,339
Closed -$335K 346
2025
Q1
$335K Buy
+36,339
New +$385K 0.46% 74

Other funds holding HTLD

PharVision Advisers's HTLD Position: Q1 2026 in Review

PharVision Advisers sold out of Heartland Express (HTLD) in Q1 2026, closing a stake of 40,960 shares — an estimated $370K sold.

PharVision Advisers first reported a position in HTLD in Q1 2025 and held it in 2 quarters. The position peaked at $370K in Q4 2025. 179 funds tracked by Wall St. Rank hold HTLD as of Q1 2026.

  • PharVision Advisers reported no remaining Heartland Express position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 40,960 Heartland Express shares in Q1 2026, an estimated $370K.
  • PharVision Advisers first reported a position in Heartland Express in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Heartland Express position peaked at $370K in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Heartland Express as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.